First Time Loading...
T

Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 5 870 ILS 0.95% Market Closed
Updated: May 11, 2024
TEVA
/
Income Statement
/
Income from Continuing Operations

Teva Pharmaceutical Industries Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teva Pharmaceutical Industries Ltd
Income from Continuing Operations Peer Comparison

Comparables:
TARO
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Income from Continuing Operations
-$617m
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Income from Continuing Operations
$45.6m
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
-18%
I
InterCure Ltd
TASE:INCR
Income from Continuing Operations
₪17.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Mediwound Ltd
NASDAQ:MDWD
Income from Continuing Operations
-$6.7m
CAGR 3-Years
10%
CAGR 5-Years
-3%
CAGR 10-Years
2%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Income from Continuing Operations
-₪8.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cannassure Therapeutics Ltd
TASE:CSURE
Income from Continuing Operations
-₪5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Teva Pharmaceutical Industries Ltd's Income from Continuing Operations?
Income from Continuing Operations
-617m USD

Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Income from Continuing Operations amounts to -617m USD.

What is Teva Pharmaceutical Industries Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
23%

Over the last year, the Income from Continuing Operations growth was 76%. The average annual Income from Continuing Operations growth rates for Teva Pharmaceutical Industries Ltd have been 47% over the past three years , 23% over the past five years .

ALPHA SPREAD
Join more than 136,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.